AIPLA CLE Webinar: Unified Patent Court and Unitary Patents

March 2, 2023 12:30 PM to 2:00 PM


Up to 90 CLE Minutes


Fee: View Pricing Below

Register Now

The Unified Patent Court (UPC) will most likely enter into force in early 2023. That means that applicants and proprietors of European patent applications that have been granted European patents would need to determine their strategy for their European IP.  If no action is taken, then the legal framework of the UPC will affect even the already granted EP patents. This webinar will discuss the effects of the UPC coming into force, as well as the options and decisions that the applicants and proprietors need to consider and implement.

Presented by: Dr. Malgorzata (Gosia) Kulczycka, Hickman Becker Bingham Ledesma LLP & Eric Dokter, Viering, Jentschura & Partner

This event is free to AIPLA members who are not requesting CLE. Standard webinar pricing applies to those requesting CLE. CLE is included for our All Access Pass holders and Corporate Subscribers.

Pricing below only applies to those requesting CLE

Special rate for AIPLA Solo Practitioner Members:  $65
Special rate for AIPLA Student Members:  $10

CLE Pricing


In response to Covid-19, AIPLA has put in-place a new process for Multiple Attendee Site registrations that allows each site registrant to participate in the webinar independently. Contact at least 3 business days prior to the live webinar for site registrations.

Registration includes:

  • CLE certification/processing for applicable states.  Reference CLE Information below for complete details.  
  • Webinar materials, including complete CLE processing information, accessible 24-48 hours before webinar date.

Cancellation Policy:

To get full refund, registrant must request refund five (5) days prior to live event. If less than five (5) days, registrant is transferred to product. 

System requirements: 

Webinar access is compatible with any Windows 7 or later computer, Android OS devices, or Apple/iOS devices.  Check system compatibility here.

Accessibility for hearing impaired:

AIPLA’s webinars are available and accessible to individuals who are hearing impaired. If anyone at your location would like to know more about accommodations, please contact We ask that you let us know at least 7 business days out from the webinar, to ensure that we can identify and deploy the solution that best fits our registrants needs.


CLE is approved with the following states:

  • Alaska
  • California
  • Missouri
  • New Jersey (Under New Jersey's Reciprocity Rule)
  • New York (Under New York's Approved Jurisdiction Policy)
  • Pennsylvania
  • Texas
  • Vermont

AIPLA has applied for CLE accreditation in the following states: 

  • Florida
  • Illinois
  • Minnesota
  • Ohio
  • Tennessee
  • Virginia
  • Washington
For information on CLE accreditation in all other states, please contact our CLE Department at  CLE credit may be available, but will require additional time for approval and COA delivery.

CLE Restrictions: 

ATTENTION attorneys in Louisiana, Ohio, Pennsylvania, and Utah

These states mandate attorneys can only view a webinar independently at their own computer to receive CLE credit.  Multiple attendees prohibited.

ATTENTION attorneys in Alabama and Rhode Island

AIPLA does not submit courses for approval in Alabama or Rhode Island.  Attendees needing credit in these states may select the free, no CLE option to watch the webinar and use course materials and their certificate of attendance to request course approval directly from the State Bars. 

ATTENTION attorneys in Arizona

Arizona does not certify courses or providers. Arizona lawyers are required to independently review AZ's regulations and make their own determination that it qualifies for credit towards their MCLE requirements. MCLE Regulation 104(A) identifies the standards to apply.  AIPLA will email an attendance affidavit to registrants requesting AZ CLE credit after the webinar.

ATTENTION attorneys in New Hampshire

New Hampshire attendees must self-determine whether a program is eligible for credit, and self-report their attendance according to NH Supreme Court Rule 53.  The New Hampshire Minimum Continuing Legal Education (NHMCLE) Board does not approve or accredit CLE activities for the NH Minimum CLE requirement.  AIPLA will email an attendance affidavit to registrants requesting NH CLE credit after the webinar.   

 Disclaimer:  AIPLA is a nonprofit national bar association.  The sole purpose of this CLE program is to provide educational and informational content.  AIPLA does not provide legal services or advice.  The opinions, views and other statements expressed by contributors to this CLE program are solely those of the contributors.  These opinions, views and statements of the contributors do not necessarily represent those of AIPLA and should not be construed as such.


Add to:




  • AIPLA Comments on Inventorship Guidance for AI-Assisted Inventions

    May 15, 2024

    Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO in response to the recently-published Inventorship Guidance for AI-Assisted Inventions.
  • USPTO Building AIPLA Comments to USPTO on Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace

    May 14, 2024

    Arlington, VA. May 14, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the USPTO’s Request for Comment regarding Unlocking the Full Potential of Intellectual Property by Translating More Innovation to the Marketplace.
  • AIPLA Files Amicus Brief in REGENXBIO Inc. v. Sarepta Therapeutics, Inc.

    May 14, 2024

    Arlington, VA. May 10, 2024 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief in support of neither party with the Court of Appeals for the Federal Circuit in REGENXBIO Inc. v. Sarepta Therapeutics, Inc., a case on appeal from the U.S. District Court for the District of Delaware. The district court held that cultured host cells containing a recombinant nucleic acid molecule were not eligible for patent protection under Section 101 of the Patent Act because the individual nucleic acid sequences used in the recombinant molecule were not modified or changed from their naturally occurring state.
  • Supreme Court Affirms Eleventh Circuit’s Ruling in Warner Chappell Music, Inc. v. Sherman Nealy

    May 9, 2024

    On May 9, 2024, the Supreme Court issued a 6-3 decision in Warner Chappell Music, Inc., et al. v. Sherman Nealy, et al., affirming the Eleventh Circuit’s ruling that, provided suit is timely filed under the discovery rule, copyright damages are recoverable for infringements occurring prior to the Copyright Act’s three-year statute of limitations. The majority opinion is consistent with the amicus brief filed by AIPLA on December 1, 2023. To read the opinion of the Court, please click here.
  • AIPLA Comments to Copyright Office on Group Registration of Two-Dimensional Artwork

    April 2, 2024

    Arlington, VA. April 1, 2024 - The American Intellectual Property Law Association (AIPLA) submitted comments in response to the U.S. Copyright Office's Notice of Proposed Rulemaking related to group registration of two-dimensional artwork.